MP07-Bases Fisiopatologia y Terapeutica Medica
Medicina de precisión / IBS-MP07
Grupo de investigación dedicado a profundizar en el conocimiento de las enfermedades autoinmunes sistémicas desde el punto de vista epidemiológico, clínico, genético y de inmunología básica. Además, trabaja en el estudio de los factores de riesgo asociados con el desarrollo de osteoporosis esteroidea, así como de su prevención y tratamiento.
Palabras clave
Enfermedades Autoinmunes, Lupus, Esclerodermia, Vasculitis Sistémicas, Uveitis, Osteoporosis Y Glucocorticoídes.
JOSE LUIS CALLEJAS RUBIO
MARIA CORREA RODRIGUEZ
MARIA CONCEPCION FERNANDEZ ROLDAN
ANA MARIA MARQUEZ ORTIZ
NORBERTO ORTEGO CENTENO
GABRIELA POCOVI
RAQUEL RIOS FERNANDEZ
BLANCA Mª RUEDA MEDINA
Effectiveness of Quinacrine (Mepacrine) in Photosensitive Autoimmune Diseases, Lupus Erythematosus, and Dermatomyositis: Report on 38 Cases and Literature Review
ARCHIVES OF RHEUMATOLOGY, 2019;
FI:0,274; Q4
Diet Quality and High-Sensitivity C-Reactive Protein in Patients With Systemic Lupus Erythematosus
BIOLOGICAL RESEARCH FOR NURSING, 2019;
FI:1,513; Q2
Association of physical fitness components and health-related quality of life in women with systemic lupus erythematosus with mild disease activity
PLOS ONE, 2019;
FI:2,776; Q2
Association of Functional Polymorphisms of KIR3DL1/DS1 With Behcet’s Disease
FRONTIERS IN IMMUNOLOGY, 2019;
FI:4,716; Q2
Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis
FRONTIERS IN IMMUNOLOGY, 2019;
FI:4,716; Q2
Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity
LUPUS, 2018;
FI:2,969; Q3
Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group
RHEUMATOLOGY INTERNATIONAL, 2018;
FI:1,952; Q4
Dietary intake and nutritional status in patients with systemic lupus erythematosus
ENDOCRINOLOGIA DIABETES Y NUTRICION, 2018;
Q4
Aortitis as a Rare Cause of Aortic Aneurysm and Valve Regurgitation: Is Repair Precluded?
CASE REPORTS IN CARDIOLOGY, 2018;
Association between perceived level of stress, clinical characteristics and psychopathological symptoms in women with systemic lupus erythematosus
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018;
FI:3,201; Q2
Autoinflammatory diseases in adults. Clinical characteristics and prognostic implications
REVISTA CLINICA ESPANOLA, 2017;
FI:0,971; Q3
Dress syndrome and bilateral panuveitis caused by strontium ranelate
MEDICINA CLINICA, 2017;
FI:1,125; Q3
Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017;
FI:2,634; Q3
Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017;
FI:2,634; Q3
Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE)
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017;
FI:2,634; Q3
Serosal involvement in IgG4-related disease: report of two cases and review of the literature
RHEUMATOLOGY INTERNATIONAL, 2016;
FI:1,702; Q3
Subclinical arteriosclerosis and osteoprotegerin levels in a population with systemic lupus erythematous in the south of Europe
LUPUS, 2016;
FI:2,118; Q3
Pulmonary Langerhans Histiocytosis: an uncommon cause of interstitial pneumonia in a patient with Sjogren syndrome
CLINICAL RHEUMATOLOGY, 2016;
FI:2,042; Q3
Low bone mass and carotid atherosclerosis in lupus erythematosus patients from Granada, a city in the south of Spain
LUPUS, 2016;
FI:2,118; Q3
The effects of corticosteroids on cognitive flexibility and decision-making in women with lupus
LUPUS, 2016;
FI:2,118; Q3
Variants of the IFI16 Gene Affecting the Levels of Expression of mRNA Are Associated with Susceptibility to Behcet Disease
JOURNAL OF RHEUMATOLOGY, 2015;
FI:3,187; Q2
Antiphospholipid syndrome, antiphospholipid antibodies and solid organ transplantation
LUPUS, 2015;
FI:2,197; Q3
Pyoderma gangrenosum and systemic lupus erythematosus: a report of five cases and review of the literature
LUPUS, 2015;
FI:2,197; Q3
The role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupus erythematosus
LUPUS, 2015;
FI:2,197; Q3
Association of HLA-DRB1*01 With IgA Vasculitis (Henoch-Schonlein)
ARTHRITIS & RHEUMATOLOGY, 2015;
Q4
Detección Precoz de Osteoporosis: Identificación de Factores Genéticos Implicados en la Mineralización Ósea en Adultos Jóvenes
Financiador: FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD
Número de expediente: PI-0414-2014
Tiempo de ejecución: 31/07/2015 - 01/08/2017
IP: BLANCA Mª RUEDA MEDINA
Identificación de Factores Genéticos Implicados en el Desarrollo de Úlceras Digitales en Pacientes de Esclerodermia Mediante Un Estudio de Asociación del Genoma Completo (Gwas)
Financiador: FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD
Número de expediente: PI-0390-2014
Tiempo de ejecución: 31/07/2015 - 01/08/2017
IP: ANA MARIA MARQUEZ ORTIZ
Lydimed: Lupus y Dieta Mediterránea
Financiador: CONSEJERÍA DE SALUD
Número de expediente: PI-0523-2016
Tiempo de ejecución: 01/01/2017 - 31/12/2019
IP: NORBERTO ORTEGO CENTENO
Identificación de Factores Genéticos de Riesgo Compartidos Entre Enfermedades Reumáticas Mediante Una Estrategia Meta-Immunochip
Financiador: CONSEJERÍA DE SALUD
Número de expediente: PI-0493-2016
Tiempo de ejecución: 01/01/2017 - 31/12/2019
IP: RAQUEL RIOS FERNANDEZ
Study of the molecular basis of giant cell arteritis by integrating genomic, transcriptomic and methylation data.
Financiador: INSTITUTO DE SALUD CARLOS III
Número de expediente: CP17/00008-P
Tiempo de ejecución: 01/01/2018 - 31/12/2020
IP: ANA MARIA MARQUEZ ORTIZ
Identificación de los mecanismos patogénicos implicados en el desarrollo de la arteritis de células gigantes mediante secuenciación del transcriptoma de células T individuales
Financiador: INSTITUTO DE SALUD CARLOS III
Número de expediente: PI18/00040
Tiempo de ejecución: 01/01/2019 - 31/12/2021
IP: ANA MARIA MARQUEZ ORTIZ